Recent advances in the management of knee osteoarthritis: a narrative review
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 21, 2025
Knee
osteoarthritis
(OA)
is
a
common
condition
that
causes
pain
and
reduces
the
quality
of
life
for
many
people.
It
also
leads
to
high
health
financial
costs.
Managing
knee
OA
requires
using
different
methods
together
best
results.
This
review
overviews
current
therapeutic
options
pain,
focusing
on
their
efficacy,
safety,
potential
roles
in
clinical
practice.
Topical
treatments,
such
as
NSAIDs
capsaicin,
offer
significant
relief
with
minimal
systemic
side
effects
are
suitable
initial
therapy,
nonpharmacologic
interventions
like
exercise
and,
when
relevant,
weight
loss.
Oral
analgesics,
including
acetaminophen
opioids,
have
limited
efficacy
serious
effects,
making
them
appropriate
only
short-term
or
rescue
therapy.
Intra-articular
injections,
corticosteroids,
hyaluronic
acid,
platelet
rich
plasma,
demonstrate
varying
levels
safety.
Nutritional
supplements,
curcumin,
Boswellia
serrata
,
glucosaminechondroitin
combinations,
modest
benefits
used
adjuncts
standart
treatment.
Nonpharmacological
transcutaneous
electrical
nerve
stimulation
(TENS),
acupuncture,
local
heat
provide
variable
should
be
customized
based
individual
patient
responses.
Targeted
biologic
agents,
antibodies
TNF-α,
IL-1,
NGF,
hold
promise
more
precise
relief;
however,
further
research
required
establish
routine
use.
Treating
personalized,
combining
several
methods.
Research
must
continue
improve
treatments
make
safer.
Language: Английский
Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential
Diseases,
Journal Year:
2024,
Volume and Issue:
12(9), P. 226 - 226
Published: Sept. 23, 2024
Systemic
lupus
erythematosus
(SLE)
is
a
complex
autoimmune
disorder
characterized
by
the
presence
of
various
serum
autoantibodies
and
multi-system
effects,
predominantly
affecting
young
female
patients.
The
pathogenesis
SLE
involves
combination
genetic
factors,
environmental
triggers,
pathogen
invasions
that
disrupt
immune
cell
activation,
leading
to
release
chronic
inflammation.
Mitochondria,
as
primary
cellular
powerhouses,
play
crucial
role
in
development
through
their
control
energy
generation,
reactive
oxygen
species
(ROS)
production,
apoptotic
pathways.
Dysregulation
mitochondrial
structure
function
can
contribute
dysregulation,
oxidative
stress,
inflammation
seen
SLE.
Recent
research
has
highlighted
impact
dysfunction
on
cells
involved
pathogenesis,
such
T-lymphocytes,
B-lymphocytes,
neutrophils,
plasmacytoid
dendritic
cells.
Mitochondrial
these
leads
increased
ROS
disrupted
mitophagy,
alterations
metabolism,
contributing
dysregulation
Moreover,
variations
DNA
(mtDNA)
abnormalities
dynamics
have
been
linked
SLE,
exacerbating
stress
abnormalities.
Targeting
emerged
promising
therapeutic
approach
for
Drugs
sirolimus,
N-acetylcysteine,
coenzyme
Q10,
metformin
shown
potential
restoring
homeostasis,
reducing
modulating
responses
These
agents
demonstrated
efficacy
preclinical
models
clinical
studies
improving
disease
activity,
autoantibody
titers,
ameliorating
organ
damage
In
conclusion,
this
review
underscores
critical
mitochondria
targeting
novel
strategy
outcomes
Further
investigation
into
mechanisms
underlying
involvement
targeted
therapies
hold
promise
advancing
treatment
enhancing
patient
care.
Language: Английский
Metformin in Antiviral Therapy: Evidence and Perspectives
Viruses,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1938 - 1938
Published: Dec. 18, 2024
Metformin,
a
widely
used
antidiabetic
medication,
has
emerged
as
promising
broad-spectrum
antiviral
agent
due
to
its
ability
modulate
cellular
pathways
essential
for
viral
replication.
By
activating
AMPK,
metformin
depletes
energy
reserves
that
viruses
rely
on,
effectively
limiting
the
replication
of
pathogens
such
influenza,
HIV,
SARS-CoV-2,
HBV,
and
HCV.
Its
role
in
inhibiting
mTOR
pathway,
crucial
protein
synthesis
reactivation,
is
particularly
significant
managing
infections
caused
by
CMV,
EBV.
Furthermore,
reduces
oxidative
stress
reactive
oxygen
species
(ROS),
which
are
critical
replicating
arboviruses
Zika
dengue.
The
drug
also
regulates
immune
responses,
differentiation,
inflammation,
disrupting
life
cycle
HPV
potentially
other
viruses.
These
diverse
mechanisms
suppress
replication,
enhance
system
functionality,
contribute
better
clinical
outcomes.
This
multifaceted
approach
highlights
metformin’s
potential
an
adjunctive
therapy
treating
wide
range
infections.
Language: Английский
The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules
Eun Ju Kim,
No information about this author
Hye‐Seon Jeong,
No information about this author
Jiyeon Park
No information about this author
et al.
Journal of Controlled Release,
Journal Year:
2024,
Volume and Issue:
378, P. 490 - 502
Published: Dec. 24, 2024
Language: Английский
Metabolic Side Effects from Antipsychotic Treatment with Clozapine Linked to Aryl Hydrocarbon Receptor (AhR) Activation
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(10), P. 2294 - 2294
Published: Oct. 10, 2024
Metabolic
syndrome
(MetS)
is
the
most
common
adverse
drug
reaction
from
psychiatric
pharmacotherapy.
Neuroreceptor
blockade
by
antipsychotic
clozapine
induces
MetS
in
about
30%
of
patients.
Similar
to
insulin
resistance,
impedes
Akt
kinase
activation,
leading
intracellular
glucose
and
glutathione
depletion.
Additional
cystine
shortage
triggers
tryptophan
degradation
kynurenine,
which
a
well-known
AhR
ligand.
Ligand-bound
downregulates
iron
pool,
thereby
increasing
risk
mitochondrial
dysfunction.
Scavenging
stabilizes
transcription
factor
HIF-1,
shifts
metabolism
toward
transient
glycolysis.
Furthermore,
inhibits
AMPK
obesity
liver
steatosis.
Increasing
uptake
activation
prevents
dyslipidemia
damage
and,
therefore,
reduces
MetS.
In
line
with
vitro
results,
feeding
experiments
rats
revealed
disturbed
glucose-/lipid-/iron-metabolism
treatment
hyperglycemia
hepatic
deposits
female
steatosis
anemia
male
animals.
Decreased
energy
expenditure
seems
be
cause
fast
weight
gain
first
weeks
treatment.
patients,
this
due
neuroleptic
correlates
an
improvement
psychotic
syndromes
can
even
used
anticipate
therapeutic
effect
Language: Английский
Metformin: Beyond Type 2 Diabetes Mellitus
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 17, 2024
Metformin
was
developed
from
an
offshoot
of
Guanidine.
It
is
known
to
be
the
first-line
medication
for
type
2
diabetes
mellitus,
polycystic
ovarian
syndrome,
and
weight
reduction.
has
also
been
shown
have
effectiveness
in
management
non-alcoholic
fatty
liver
disease
(NAFLD),
cirrhosis,
various
carcinomas
like
hepatocellular,
colorectal,
prostate,
breast,
urinary
bladder,
blood,
melanoma,
bone,
skin,
lung
so
on.
This
narrative
review
focuses
on
effect
metformin
disease,
hepatocellular
carcinoma.
The
search
platforms
topic
were
PubMed,
Scopus,
Google
engine.
Critical
words
searching
included
'Metformin,'
AND
'Indications
Metformin,'
'Non-Alcoholic
Fatty
Liver
Disease,'
'Metformin
mechanism
action,'
'NAFLD
management,'
inflammation,'
insulin,'
'Liver
cirrhosis,'
'Hepatocellular
carcinoma.'
Lifestyle
modification
use
hypoglycemic
agents
can
help
improve
conditions.
several
mechanisms
that
enhance
health,
including
reducing
reactive
oxygen
species,
nuclear
factor
kappa
beta
(NF-κB),
enzymes,
improving
insulin
sensitivity,
hepatic
cell
lipophagy.
Long-term
may
cause
some
adverse
effects
lactic
acidosis
gastrointestinal
disturbance.
long-term
overdose
lead
a
rise
hydrogen
sulfide
cells,
which
calls
pharmacovigilance.
Drug
regulating
authorities
should
provide
approval
further
research,
national
international
guidelines
need
diseases,
perhaps
with
inclusion
as
part
regime.
Language: Английский
Effect of metformin on the neuronal morphology of frontal cortex and hippocampal regions in lipopolysaccharide induced neuroinflammation in male Wistar rats
Translational Research in Anatomy,
Journal Year:
2024,
Volume and Issue:
38, P. 100365 - 100365
Published: Nov. 12, 2024
Language: Английский
An Updated Review on Repurposing of Metformin
Hind A Rikabi,
No information about this author
Dalia A. Abdulla,
No information about this author
Mahmoud M. E. Mudawi
No information about this author
et al.
Asian Journal of Pharmaceutical Research and Health Care,
Journal Year:
2024,
Volume and Issue:
16(4), P. 344 - 351
Published: Oct. 1, 2024
A
BSTRACT
Even
with
the
swift
progress
in
scientific
understanding
of
various
diseases
such
as
cancer,
cardiovascular
diseases,
and
diabetes,
there
remains
a
need
for
effective
new
treatments.
Now,
other
drug
development
strategies,
repurposing
existing
medicines
to
treat
which
will
save
time
money,
are
being
investigated.
Since
metformin
is
one
most
used
drugs
worldwide
it
investigated
uses,
therefore,
this
review
potential
uses
beyond
its
established
use
diabetes
highlighted
several
polycystic
ovary
syndrome
(PCOS),
weight
reduction,
lowering
plasma
lipids,
delaying
aging
process,
possible
role
reducing
mortality
pandemic
COVID-19.
An
extensive
literature
search
was
conducted
on
PubMed
Google
Scholar
databases
identify
relevant
literature.
Language: Английский